vs

Side-by-side financial comparison of CHICAGO RIVET & MACHINE CO (CVR) and Relay Therapeutics, Inc. (RLAY). Click either name above to swap in a different company.

Relay Therapeutics, Inc. is the larger business by last-quarter revenue ($7.0M vs $6.0M, roughly 1.2× CHICAGO RIVET & MACHINE CO). CHICAGO RIVET & MACHINE CO produced more free cash flow last quarter ($24.3K vs $-235.9M).

Chicago Pneumatic, also known as "CP", is an industrial manufacturer providing power tools, air compressors, generators, light towers and hydraulic equipment. Products are sold in more than 150 countries through a worldwide distribution network. CP is active on markets such as tools for industrial production, vehicle service, maintenance repair operation for mining, construction, infrastructure equipment.

Relay Therapeutics is a clinical-stage biotechnology company focused on developing precision oncology therapies. It leverages advanced computational modeling of protein dynamics, paired with cutting-edge experimental biology, to design targeted medicines for previously intractable cancer types, serving global oncology care markets and patient populations.

CVR vs RLAY — Head-to-Head

Bigger by revenue
RLAY
RLAY
1.2× larger
RLAY
$7.0M
$6.0M
CVR
More free cash flow
CVR
CVR
$235.9M more FCF
CVR
$24.3K
$-235.9M
RLAY

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CVR
CVR
RLAY
RLAY
Revenue
$6.0M
$7.0M
Net Profit
$-1.2M
Gross Margin
2.7%
Operating Margin
-15.3%
Net Margin
-19.3%
Revenue YoY
45.9%
Net Profit YoY
68.0%
EPS (diluted)

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CVR
CVR
RLAY
RLAY
Q4 25
$6.0M
$7.0M
Q3 25
$7.4M
$0
Q2 25
$7.3M
Q1 25
$7.2M
$7.7M
Q4 24
$4.1M
$0
Q3 24
$7.0M
$0
Q2 24
$8.1M
$0
Q1 24
$7.9M
$10.0M
Net Profit
CVR
CVR
RLAY
RLAY
Q4 25
$-1.2M
Q3 25
$67.6K
$-74.1M
Q2 25
$-395.0K
Q1 25
$401.0K
$-77.1M
Q4 24
$-3.6M
Q3 24
$-1.4M
$-88.1M
Q2 24
$142.1K
$-92.2M
Q1 24
$-698.0K
$-81.4M
Gross Margin
CVR
CVR
RLAY
RLAY
Q4 25
2.7%
Q3 25
18.1%
Q2 25
13.4%
Q1 25
22.9%
Q4 24
-43.7%
Q3 24
10.0%
Q2 24
17.6%
Q1 24
9.5%
Operating Margin
CVR
CVR
RLAY
RLAY
Q4 25
-15.3%
Q3 25
0.9%
Q2 25
-5.7%
Q1 25
1.0%
-1105.2%
Q4 24
-86.4%
Q3 24
-11.8%
Q2 24
1.3%
Q1 24
-11.5%
-903.0%
Net Margin
CVR
CVR
RLAY
RLAY
Q4 25
-19.3%
Q3 25
0.9%
Q2 25
-5.4%
Q1 25
5.5%
-1003.6%
Q4 24
-88.0%
Q3 24
-20.8%
Q2 24
1.8%
Q1 24
-8.9%
-813.3%
EPS (diluted)
CVR
CVR
RLAY
RLAY
Q4 25
Q3 25
$-0.43
Q2 25
Q1 25
$-0.46
Q4 24
Q3 24
$-0.63
Q2 24
$-0.69
Q1 24
$-0.62

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CVR
CVR
RLAY
RLAY
Cash + ST InvestmentsLiquidity on hand
$1.7M
$84.0M
Total DebtLower is stronger
Stockholders' EquityBook value
$18.8M
$567.1M
Total Assets
$23.3M
$621.3M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CVR
CVR
RLAY
RLAY
Q4 25
$1.7M
$84.0M
Q3 25
$1.7M
$91.6M
Q2 25
$1.2M
Q1 25
$765.6K
$93.5M
Q4 24
$2.2M
$124.3M
Q3 24
$2.2M
$152.4M
Q2 24
$2.6M
$134.1M
Q1 24
$2.7M
$152.9M
Total Debt
CVR
CVR
RLAY
RLAY
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
$0
Q3 24
Q2 24
Q1 24
Stockholders' Equity
CVR
CVR
RLAY
RLAY
Q4 25
$18.8M
$567.1M
Q3 25
$20.0M
$607.7M
Q2 25
$20.0M
Q1 25
$20.4M
$721.1M
Q4 24
$20.0M
$777.8M
Q3 24
$23.7M
$838.9M
Q2 24
$25.2M
$681.7M
Q1 24
$25.2M
$745.8M
Total Assets
CVR
CVR
RLAY
RLAY
Q4 25
$23.3M
$621.3M
Q3 25
$24.0M
$670.0M
Q2 25
$23.6M
Q1 25
$24.1M
$799.4M
Q4 24
$23.4M
$871.3M
Q3 24
$26.4M
$930.1M
Q2 24
$27.3M
$772.5M
Q1 24
$27.8M
$841.4M
Debt / Equity
CVR
CVR
RLAY
RLAY
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
0.00×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CVR
CVR
RLAY
RLAY
Operating Cash FlowLast quarter
$116.4K
$-235.5M
Free Cash FlowOCF − Capex
$24.3K
$-235.9M
FCF MarginFCF / Revenue
0.4%
-3370.0%
Capex IntensityCapex / Revenue
1.5%
5.9%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-1.6M
$-622.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CVR
CVR
RLAY
RLAY
Q4 25
$116.4K
$-235.5M
Q3 25
$638.0K
$-62.1M
Q2 25
$28.2K
Q1 25
$-2.0M
$-73.2M
Q4 24
$-60.1K
$-249.1M
Q3 24
$-58.2K
$-75.1M
Q2 24
$363.5K
$-65.8M
Q1 24
$-398.8K
$-50.3M
Free Cash Flow
CVR
CVR
RLAY
RLAY
Q4 25
$24.3K
$-235.9M
Q3 25
$492.1K
$-62.1M
Q2 25
$-22.8K
Q1 25
$-2.1M
$-73.6M
Q4 24
$-118.1K
$-251.1M
Q3 24
$-368.9K
$-75.3M
Q2 24
$58.0K
$-65.8M
Q1 24
$-491.8K
$-52.1M
FCF Margin
CVR
CVR
RLAY
RLAY
Q4 25
0.4%
-3370.0%
Q3 25
6.7%
Q2 25
-0.3%
Q1 25
-28.3%
-958.4%
Q4 24
-2.9%
Q3 24
-5.3%
Q2 24
0.7%
Q1 24
-6.3%
-520.7%
Capex Intensity
CVR
CVR
RLAY
RLAY
Q4 25
1.5%
5.9%
Q3 25
2.0%
Q2 25
0.7%
Q1 25
0.6%
5.0%
Q4 24
1.4%
Q3 24
4.5%
Q2 24
3.8%
Q1 24
1.2%
17.8%
Cash Conversion
CVR
CVR
RLAY
RLAY
Q4 25
Q3 25
9.44×
Q2 25
Q1 25
-5.01×
Q4 24
Q3 24
Q2 24
2.56×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CVR
CVR

Fastener$5.1M85%
Other$890.7K15%

RLAY
RLAY

Segment breakdown not available.

Related Comparisons